The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome

Human Reproduction Update

Volumn 3, Issue 3, 1997, Pages 255-266

  Rizk, Botros ^a,e   Aboulghar, Mohamed ^b   Smitz, Johan ^c   Ron El, Raphael ^d  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b CAIRO UNIVERSITY   (Egypt)

^c CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^d IVF Infertility Unit   (Israel)

^e Div of Reproductive Endocrinology   (United States)

Author keywords

Cytokines; Interleukins; Ovarian hyperstimulation syndrome; Ovulation induction; Vascular endothelial growth factor

Indexed keywords

ACUTE PHASE PROTEIN; CHEMOATTRACTANT; CHORIONIC GONADOTROPIN; CYTOKINE; ESTROGEN; HEPARIN BINDING PROTEIN; HISTAMINE; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN DERIVATIVE; LUTEINIZING HORMONE; MESSENGER RNA; PROLACTIN; PROSTAGLANDIN; VASCULOTROPIN;

ANGIOGENESIS; ASCITES; CAPILLARY PERMEABILITY; CELL PROLIFERATION; DOSE RESPONSE; ENDOTHELIUM CELL; GRANULOSA CELL; HEMATOCRIT; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LEUKOCYTOSIS; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; OVARY DISEASE; OVARY FOLLICLE FLUID; OVULATION INDUCTION; PERITONEAL FLUID; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; THECA CELL;

ANIMALS; ASCITIC FLUID; CAPILLARY PERMEABILITY; CHORIONIC GONADOTROPIN; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKINS; LYMPHOKINES; OVARIAN HYPERSTIMULATION SYNDROME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030824609     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/3.3.255     Document Type: Review

References (109)

1. Abdalla, H.I. and Rizk, B. (1997) Infertility Diagnosis and Management. Health Press, Oxford, in press.
2. Aboulghar, M.A., Mansour, R.T., Serour, G.I. et al. (1992a) Autotransfusion of the ascitic fluid in the treatment of severe ovarian hyperstimulation syndrome (OHSS). Fertil. Steril, 58, 1056-1059.
3. Aboulghar, M.A., Mansour, R.T., Serour, G.I. et al. (1992b) Follicular aspiration does not protect against the development of ovarian hyperstimulation syndrome. J. Assist. Reprod. Genet., 9, 238-243.
4. Aboulghar, M.A., Mansour, R.T., Serour, G.I. et al. (1993) Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy. Obstet. Gynecol., 81, 108-111.
5. Aboulghar, M.A., Mansour, R.T., Serour, G.I. and Rizk, B. (1996) Ovarian hyperstimulation syndrome: Modern concepts in pathophysiology and management. Middle East Fertil. Soc. J., 1, 3-16.
6. Abramov, Y., Schenker, J.G., Lewin, A. et al. (1996) Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum. Reprod., 11, 1381-1386.
7. Adashi, E.Y. (1990) The potential relevance of cytokines to ovarian physiology: the emerging role of resident ovarian cells of the white blood cell series. Endocr. Rev., 11, 454-464.
8. Arici, A., Tazuke, S.I., Attar, E. et al. (1996) Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum. Reprod., 2, 40-45.
9. Asch, R.H., Li, H.P., Balmeceda, J.P. et al. (1991) Severe ovarian hyperstimulation syndrome in assisted reproductive technology; definition of high risk groups. Hum. Reprod., 6, 1395-1399.
10. Asch, R.H., Ivery, G., Goldsman, M. et al. (1993) The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Hum. Reprod., 8, 1015-1020.
11. Balasch, J., Arroyo, V., Carmona, F. et al. (1991) Severe ovarian hyperstimulation syndrome the role of peripheral vasodilation. Fertil. Steril., 56, 1077-1083.
12. Barak, V., Mordel, N., Zajicek, G. et al. (1992) The correlation between interleukin 2 and interleukin 2 receptors to oestradiol, progesterone and testosterone levels in preovulatory follicles of in vitro fertilization patients. Hum. Reprod., 7, 926-929.
13. Bassett, D.L. (1943) The changes in the vascular pattern of the ovary of the albino rat during the estrus cycle. Am. J. Anat., 73, 251-291.
14. Berg, P.A. and Navot, D. (1992) Ovarian hyperstimulation syndrome: a review of pathophysiology. J. Assist. Reprod. Genet., 9, 429-438.
15. Buyalos, R.P., Watson, J.M. and Martinez, M.O. (1992) Detection of IL-6 in human follicular fluid. Fertil. Steril., 57, 1230-1234.
16. Cavender, J.L. and Murdoch, W.J. (1988) Morphological studies of the microcirculatory system of preovulatory ovine follicles. Biol. Reprod., 39, 989-997.
17. Charnock-Jones, D.S., Sharkey, A.M., Rajput-Williams, J. et al. (1993) Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell line. Biol. Reprod., 48, 1120-1128.
18. Cholst, I., Troffa, C., Weintraub, I. and Sealey, J.E. (1986) Plasma prorenin, LH, and estradiol relationships during the early luteal phase of the menstrual cycle. 68th Annual Meeting of the Endocrine Society, Anaheim, CA, p. 74 (Abstr. 173).
19. Connolly, D.T., Heuvelman, D.M., Nelson, R. et al. (1993) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis, J. Clin. Invest., 84, 1470-1478.
20. Damas, P., Ledoux, D., Nys, M. et al. (1992) Cytokine serum level during severe sepsis in humans IL-6 as a marker of severity. Ann. Surg., 215, 356-362.
21. Dinarello, C.A. (1989) Interleukin-1 and its related cytokines. Adv. Immunol., 44, 153-205.
22. Donnez, J., Langerock, S. and Thomas, K. (1982) Peritoneal fluid volume and 17 b-estradiol and progesterone concentrations in ovulatory, anovulatory, and postmenopausal women. Obstet. Gynecol., 59, 687-692.
23. Erlik, Y., Naot, Y. and Friedman, M. (1979) Histamine levels in ovarian hyperstimulation syndrome. Obstet. Gynecol., 53, 580.
24. Fernandez, L.A., Tarlatzis, B.C., Rzasa, P.J. et al. (1985) Renin-like activity on ovarian follicular fluid. Fertil. Steril., 44, 219-223.
25. Ferrara, N., Houck, K.A., Jakeman, L.B. et al. (1991) The vascular endothelial growth factor family of polypeptides. J. Cell. Biol., 47, 211-218.
26. Ferrara, N., Houck, K., Jakeman, L. and Leung, D. (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev., 13, 18-32.
27. Finkel, M.S., Oddis, C.V., Jacob, T.D. et al. (1992) Negative isotropic effects of cytokines on the heart mediated by nitric oxide. Science, 257, 387-389.
28. Frederick, J.L., Shimanuki, T. and DiZerega, G.S. (1984) Initiation of angiogenesis by human follicular fluid. Science, 224, 389-390.
29. Friedlander, M.A., de Mola, J.R. and Goldfarb, J.M. (1993) Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome. Fertil. Steril., 60, 826-832.
30. Goldsman, M.P., Perdam, A., Dominguez, C.E. et al. (1995) Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil. Steril., 63, 268-272.
31. Gordon, J.D., Mesiano, S., Zaloudek, C.J. et al. (1996) Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J. Clin. Endocrinol. Metab., 81, 353-359.
32. Gregly, R.Z., Poldi, E., Erlik, Y. and Markler, A. (1976) Treatment of ovarian hyperstimulation syndrome by antihistamine. Obstet. Gynecol., 47, 83.
33. Hollenberg, S.M., Cunnion, R.E. and Parrillo, J.E. (1991) The effect of TNF on vascular smooth muscle. Chest, 100, 1122-1127.
34. Jakob, W., Jentrsch, K.D., Maursberger, B. and Oehme, P. (1977) Demonstration of angiogenesis activity in the corpus luteum of cattle. Exp. Pathol., 13, 231-236.
35. Kamat, B.R., Brown, L.F., Manseau, E.J. et al. (1995) Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Am. J. Pathol., 146, 157-165.
36. Katz, Z., Lancet, M., Borenstein, R. and Chenke, J. (1984) Absence of teratogenicity of indomethacin in ovarian hyperstimulation syndrome. Int. J. Fertil., 29, 186.
37. Keck, P.J., Hauser, S.D., Krivi, G. et al. (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science, 246, 1309-1312.
38. Kendall, R.L. and Thomas, K.A. (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA, 90, 10705-10709.
39. Kim, K.J., Li, B., Winer, J. et al. (1993) Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo. Nature, 362, 841-844.
40. Kishimoto, T. (1989) The biology of IL-6. Blood, 74, 1-10.
41. Knox, G.E. (1974) Antihistamine blockage of the ovarian hyperstimulation syndrome. Am. J. Obstet. Gynecol., 118, 992-994.
42. Koch, A.E., Harlow, L.A., Haines, G.K. et al. (1994) Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol., 152, 4149-4156.
43. Konickx, P.R., Renaer, M. and Brosens, I.A. (1980a) Origin of peritoneal fluid in women. An ovarian exudation product. Br. J. Obstet. Gynaecol., 87, 177-183.
44. Konickx, P.R., Heyns, W., Verhoeven, G. et al. (1980b) Biochemical characterization of peritoneal fluid in women during the menstrual cycle. J Clin. Endocrinol. Metab., 51, 1239-2344.
45. Krasnow, J.J., Berga, S.L., Guzick, D.S. et al. (1996) Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome. Fertil. Steril., 65, 552-555.
46. Laufer, N., Tarlatzis, B., DeCherney, A.H. et al. (1984) Asynchrony between human cumulus-corona cell complex (CCC) and oocyte maturation after human menopausal gonadotropin (HMG) treatment for in vitro fertilization (IVF). Fertil. Steril., 42, 366-372.
47. Loret de Mola, J.R., Flores, J.P., Baumgardner, G.P. et al. (1996a) Elevated interleukin-6 levels in the ovarian hyperstimulation syndrome: ovarian immunohistochemical localization of interleukin-6 signal. Obstet. Gynecol., 87, 581-587.
48. Loret de Mola, J.R., Baumgardner, G.P., Goldfarb, J.M. et al. (1996b) Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumor necrosis factor-I cannot predict its occurrence. Hum. Reprod., 11, 1377-1380.
49. Loukides, J.A., Loy, R.A., Edwards, R. et al. (1990) Human follicular fluids contain tissue macrophages. J. Clin. Endocrinol. Metab., 71, 1363-1367.
50. Maathuis, J.B., Van Look, P.F. and Michie, E.A. (1978) Changes in volume, total protein and ovarian steroid concentrations of peritoneal fluid through the human menstrual cycle. J. Endocrinol., 76, 123-124.
51. McClure, N., Leya, J., Radwanska, E. et al. (1992) Luteal phase support and severe ovarian hyperstimulation syndrome. Hum. Reprod., 7, 758-764.
52. McClure, N., Healy, D.L., Rogers, P.A. et al. (1994) Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet, 344, 235-236.
53. McLaren, J., Prentice, A., Charnock-Jones, D.S. and Smith, S.K. (1996) Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum. Reprod., 11, 220-223.
54. Millauer, B., Wizigmann-Voos, S., Schnurch, H. et al. (1993) High affinity VEGF binding and developmental expression suggest FLK-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72, 835-846.
55. Morris, R.S., Wong, I.L., Kirkman, E. et al. (1995) Inhibition of ovarian-derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome. Hum. Reprod., 10, 1355-1358.
56. Motro, B., Itin, A., Sachs, L. et al. (1990) Pattern of IL-6 gene expression in vivo suggests a role for this cytokine in angiogenesis. J. Cell. Biol., 87, 3092-3096.
57. Nakamura, Y., Smith, M., Krishna, A. and Terranova, P.F. (1987) Increased number of mast cells in the dominant follicle of the cow; relationships among luteal, stromal, and hilar regions. Biol. Reprod., 37, 546-549.
58. Navot, D., Margalioth, E. and Laufer, N. (1987) Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil. Steril., 48, 57-61.
59. Neulen, J., Yan, Z., Raczek, S. et al. (1995a) Ovarian hyperstimulation syndrome: vascular endothelial growth factor/vascular permeability factor from luteinized granulosa cells is the pathophysiological principle. In Abstracts of the 11th Annual Meeting of ESHRE, Hamburg, June 1995. Hum. Repod., 10 (Abst. Bk. 2), p. 3.
60. Neulen, J., Yan, Z., Raczek, S. et al. (1995b) HCG-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J, Clin. Endocrinol. Metab., 80, 1967-1971.
61. Norman, R.J. and Wang, L.J. (1991) Tumor necrosis factor I immunoactivity in human follicular fluid and its effect on human granulosa-lutein cells. 34th Annual Meeting, The Endocrine Society of Australia Proceedings 1991, Sydney, Australia, p. 91.
62. Ong, A.C.M., Eisen, V., Rennie, D.P. et al. (1991) The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin. Clin. Endocrinol., 34, 43-49.
63. Oppenheim, J.J., Ruscetti, F.W. and Flattened, C. (1991) Cytokines. In Stites, D.P. and Terr, A.I. (eds), Basic and Clinical Immunology, 7th edn. Appleton and Lange, East Norwalk, CT, p. 78.
64. Orvieto, R., Voliovitch, I., Fishman, P. and Ben-Rafael, Z. (1995) Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study. Hum. Reprod., 10, 24-27.
65. Pellicer, A., Palumbo, A., DeCherney, A.H. and Naftolin, F. (1988) Blockage of ovulation by an angiotensin antagonist. Science, 240, 1660-1661.
66. Pellicer, A., Miru, F., Sampaia, M. et al. (1990) In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17,20 desmolase deficiency. Fertil. Steril., 55, 970-975.
67. Pepperell, J.R., Nemeth, G., Palumbo, A. and Naftolin, F. (1993) The intraovarian renin-angiotensin system. In Adashi, E.Y. and Leung, P.C.K. (eds), The Ovary. Raven Press, New York, pp. 363-380.
68. Perlman, J.M. and Volpe, J.J. (1989) Neurologic complications of captopril treatment of neonatal hypertension. Pediatrics, 83, 47-52.
69. Phillips, H.S., Hains, J., Leung, D.W. and Ferrara, N. (1990) Vascular endothelial cell growth factor is expressed in rat corpus luteum. Endocrinology, 127, 965-967.
70. Preiser, J.C., Schmartz, D., Van der Linden, P. et al. (1991) IL-6 administration has no acute hemodynamic or hematologic effect in the dog. Cytokines, 3, 1-4.
71. Pride, S.M., Ho Yuen, B. and Moon, Y.S. (1984) Clinical endocrinologic and intraovarian prostaglandin F responses to H-1 receptor blockade in the ovarian hyperstimulation syndrome: studies in the rabbit model. Am. J. Obstet. Gynecol., 148, 670-671.
72. Pride, S.M., Ho Yuen, B., Moon, Y.S. and Leyung, P.C.S. (1986) Relationship of gonadotrophin-releasing hormone, danazol and prostaglandin blockade to ovarian enlargement and ascites formation of the ovarian hyperstimulation syndrome. Am. J. Obstet. Gynecol., 154, 1155-1160.
73. Pride, S.M., James, C. and Ho Yuen, B.H. (1990) The ovarian hyperstimulation syndrome. Semin. Reprod. Endocrinol., 8, 247-260.
74. Ravindranath, N., Little-Ihrig, L.L., Phillios, H.S. et al. (1992) Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology, 131, 254-260.
75. Revel, A., Barak, V., Lavy, Y. et al. (1996) Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertil. Steril., 66, 66-71.
76. Rizk, B. (1992) Ovarian hyperstimulation syndrome. In Brinsden, P.R. and Rainsbury, P.A. (eds), A Textbook of In Vitro Fertilization and Assisted Reproduction, chapter 23. Parthenon Publishing, Carnforth, pp. 369-383.
77. Rizk, B. (1993) Ovarian hyperstimulation syndrome. In Studd, J. (ed.), Progress in Obstetrics and Gynecology, vol. II. Churchill Livingston, Edingburgh, pp. 311-349.
78. Rizk, B. and Aboulghar, M. (1991) Modern management of ovarian hyperstimulation syndrome. Hum. Reprod., 6, 1082-1087.
79. Rizk, B. and Smitz, J. (1992) Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures. Hum. Reprod., 7, 320-327.
80. Rizk, B. and Thorneycroft, I.H. (1996) Does recombinant follicle stimulating hormone abolish the risk of severe ovarian hyperstimulation syndrome? In Abstracts of the 52nd Annual Meeting of the American Society for Reproductive Medicine, Published by ASRM, S151-S152.
81. Rizk, B., Meagher, S. and Fisher, A.M. (1990) Ovarian hyperstimulation syndrome and cerebrovascular accidents. Hum. Reprod., 5, 697-698.
82. Rizk, B., Aboulghar, M.A., Mansour, R.T. et al. (1991) Severe ovarian hyperstimulation syndrome: analytical study of twenty-one cases. In Abstracts of the Proceedings of the VII World Congress on In Vitro Fertilization and Assisted Conception. Published in Hum. Reprod., Abstract Bk. pp. 368-369.
83. Ron-El, R., Herman, A., Golan, A. et al. (1991) Gonadotropins and gonadotrophins releasing hormone agonist gonadotropins protocols in a randomized prospective study. Fertil. Steril, 55, 576-578.
84. Schenker, J.G. (1995) Ovarian Hyperstimulation Syndrome. In Wallach, E.E. and Zacur, H.A. (eds), Reproductive Medicine and Surgery, chapter 35. Mosby, St. Louis, pp. 656-657.
85. Schenker, J.G. and Polishuk, W.Z. (1976) The role of prostaglandins in ovarian hyperstimulation syndrome. Obstet. Gynecol. Surv., 31, 742.
86. Schenker, J.G. and Weinstein, D. (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril., 30, 255-268.
87. Sealey, J.E., Atlas, S.A., Gloriosi, N. et al. (1985a) Cyclical secretion of prorenin during the menstrual cycle: synchronization with luteinizing hormone and progesterone. Proc. Natl. Acad. Sci. USA, 82, 8705-8709.
88. Sealey, J.E., McCord, D., Taufield, P.A. et al. (1985b) Plasma prorenin in first trimester pregnancy: relationship to changes in human chorionic gonadotropin. Am. J. Obstet. Gynecol., 153, 514-519.
89. Sealey, J.E., Glorioso, N., Istovitz, J. et al. (1986) Plasma prorenin during early pregnancy: ovarian secretion under gonadotropin control? J. Hypertension, 4 (Suppl. 5), S92-S95.
90. Sealey, J.E., Cholst, I., Glorioso, N. et al. (1987) Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle. J. Clin. Endocrinol. Metab., 63, 1-5.
91. Senger, D.R., Galli, S.J., Dvorak, A.M. et al. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascher fluid. Science, 219, 983-985.
92. Senger, D.R., Conolly, D.T., Van De Water, L. et al. (1990) Purification and NH2-terminal amino acid sequence of guinea pig tumor secreted vascular permeability factor. Cancer Res., 50, 1774-1778.
93. Senger, D.R., Van De Water, L. and Brown, L.F. (1993) Vascular permeability factor in tumor biology. Cancer Metastasis Rev., 12, 303-324.
94. Shalev, E., Giladi, Y., Matilsky, M. and Ben-Ami, M. (1995) Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in-vitro fertilization patients receiving intravenous albumin: a prospective study. Hum. Reprod., 10, 1373-1376.
95. Sifton, D.W. (ed.) (1994) Physicians Desk Reference, Medical Economics Company, Montvale, New Jersey, pp. 1556-1557.
96. Smith, K.A. (1988) Interleukin-2: inception, impact and implication. Science, 240, 1169-1176.
97. Smitz, J., Camus, M., Devroey, P. et al. (1990) Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Hum. Reprod., 5, 933-937.
98. Surrey, E.S. (1995) Hyperstimulation Syndrome. In Key, W.R., Change, R., Rebar, R.W. and Soules, M.R. (eds), Infertility Evaluation and Treatment, chapter 14. W.B. Saunders, Philadelphia, pp. 147-148.
99. Tollan, A., Holst, N., Forsdahl, F. et al. (1990) Transcapillary fluid dynamic during ovarian stimulation for in vitro fertilization. Am. J. Obstet. Gynecol, 162, 554.
100. Torry, D.S., Holt, V.J., Keenan, J.A. et al (1996) Vascular endothelial growth factor expression in cycling human endometrium. Fertil. Steril., 66, 72-80.
101. Van Beaumont, W. (1972) Evaluation of hemoconcentration from hematocrit measurements. J. Appl. Physiol., 5, 712-713.
102. Wada, I., Matson, P.L., Troup, S.A. et al. (1992) Outcome of treatment subsequent to the elective cryopreservation of all embryos from women at risk of ovarian hyperstimulation syndrome. Hum. Reprod., 7, 962-966.
103. Wada, I., Matson, P.L., Troup, S.A. et al. (1993) Does elective cryopreservation of all embryos from women at risk of ovarian hyperstimulation syndrome reduce the incidence of the condition? Br. J. Obstet. Gynaecol., 100, 265-269.
104. Wang, L.J. and Norman, R.J. (1992) Concentrations of immunoreactive interleukin-1 and interleukin-2 in human preovulatory follicular fluid. Hum. Reprod., 7, 147-150.
105. Wang, L.J., Robertson, S., Semark, R.F. and Norman, R.J. (1991) Lymphokines, including interleukin-2, alter gonadotropin-stimulated progesterone production and proliferation of human granulosa-luteal cells in vitro. J. Clin. Endocrinol. Metab., 72, 824-831.
106. Wong, G.C. and Clark, S.C. (1988) Multiple actions of IL-6 within a cytokine network, Immunol. Today, 9, 137-139.
107. Yan, Z., Weich, H.A., Bernart, W. et al. (1993) Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J. Clin. Endocrinol. Metab., 77, 1723-1725.
108. Yarali, H., Fleige-zahradka, B.G., Yuen, B.H. and McComb, P.F. (1993) The ascites in the ovarian hyperstimulation syndrome does not originate from the ovary. Fertil. Steril., 59, 657-661.
109. Zolti, M., Ben-Rafael, Z., Meirom, R. et al. (1991) Cytokine involvement in oocyte and early embryos. Fertil. Steril., 56, 265-272.